Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T56510 | Target Info | |||
Target Name | Apoptosis regulator Bcl-xL (BCL-xL) | ||||
Synonyms | Bcl2like protein 1; Bcl2L1; Bcl2-L-1; Bcl-XL; Bcl-2-like protein 1; BCLX; BCL2L; Apoptosis regulator Bcl-X | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BCL2L1 | ||||
Biochemical Class | B-cell lymphoma Bcl-2 | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 3-Nitro-N-{4-[2-(2-phenylethyl)-1,3-benzothiazol-5-YL]benzoyl}-4-{[2-(phenylsulfanyl)ethyl]amino}benzenesulfonamide | Ligand Info | |||
Canonical SMILES | C1=CC=C(C=C1)CCC2=NC3=C(S2)C=CC(=C3)C4=CC=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCCSC6=CC=CC=C6)[N+](=O)[O-] | ||||
InChI | 1S/C36H30N4O5S3/c41-36(39-48(44,45)30-17-18-31(33(24-30)40(42)43)37-21-22-46-29-9-5-2-6-10-29)27-14-12-26(13-15-27)28-16-19-34-32(23-28)38-35(47-34)20-11-25-7-3-1-4-8-25/h1-10,12-19,23-24,37H,11,20-22H2,(H,39,41) | ||||
InChIKey | KYLSTDPZEIQYFX-UHFFFAOYSA-N | ||||
PubChem Compound ID | 4369510 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 1YSN Solution structure of the anti-apoptotic protein Bcl-xL complexed with an acyl-sulfonamide-based ligand | ||||||
Method | Solution NMR | Resolution | N.A. | Mutation | No | [1] |
PDB Sequence |
MSMAMSQSNR
10 ELVVDFLSYK20 LSQKGYSWSQ30 FSDVEENRTE40 APEGTESEAV90 KQALREAGDE 100 FELRYRRAFS110 DLTSQLHITP120 GTAYQSFEQV130 VNELFRDGVN140 WGRIVAFFSF 150 GGALCVESVD160 KEMQVLVSRI170 AAWMATYLND180 HLEPWIQENG190 GWDTFVELYG 200 NNAAAESRKG210 QERLEHHHHH220 H
|
|||||
|
ALA97
2.582
GLY98
4.877
GLU100
1.668
PHE101
2.549
LEU103
4.981
ARG104
2.276
TYR105
1.725
ALA108
2.178
PHE109
4.183
LEU112
1.729
GLN115
2.600
LEU116
4.892
GLN129
4.591
VAL130
2.017
|
|||||
PDB ID: 2O1Y Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand | ||||||
Method | Solution NMR | Resolution | N.A. | Mutation | No | [2] |
PDB Sequence |
MSMAMSQSNR
10 ELVVDFLSYK20 LSQKGYSWSQ30 FSDVEENRTE40 APEGTESEAV90 KQALREAGDE 100 FELRYRRAFS110 DLTSQLHITP120 GTAYQSFEQV130 VNELFRDGVN140 WGRIVAFFSF 150 GGALCVESVD160 KEMQVLVSRI170 AAWMATYLND180 HLEPWIQENG190 GWDTFVELYG 200 NNAAAESRKG210 QERLEHHHHH220 H
|
|||||
|
ALA97
2.582
GLY98
4.877
GLU100
1.668
PHE101
2.549
LEU103
4.982
ARG104
2.276
TYR105
1.726
ALA108
2.178
PHE109
4.182
LEU112
1.729
GLN115
2.600
LEU116
4.892
GLN129
4.591
VAL130
2.017
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005 Jun 2;435(7042):677-81. | ||||
REF 2 | Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL. J Med Chem. 2007 Feb 22;50(4):641-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.